Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function

Experimental Neurology

Volumn 151, Issue 2, 1998, Pages 289-302

  Gibbs, Robert B ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alzheimer's disease; Choline acetyltransferase; Dementia; Estrogen; p75NTR; Postmenopausal women; Rats; Sex differences; trkA

Indexed keywords

CHOLINE ACETYLTRANSFERASE; ESTROGEN; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; TYROSINE KINASE RECEPTOR;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; ESTROGEN THERAPY; FOREBRAIN; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; OLIVARY NUCLEUS; OVARIECTOMY; OVARY FUNCTION; POSTMENOPAUSE; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

EID: 0032103915     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6789     Document Type: Article

References (58)

1. Altavista M. C., Rossi P., Bentivoglio A. R., Crociani P., Albanese A. Aging is associated with a diffuse impairment of forebrain cholinergic neurons. Brain Res. 508:1990;51-59.
2. Birren S. J., Verdi J. M., Anderson D. J. Membrane depolarization induces p140trk and NGF responsiveness, but not p75LNGFR, in MAH cells. Science. 257:1992;395-397.
3. Chao M. V., Hempstead B. L. p75 and Trk: A two-receptor system. Trends Neurosci. 18:1995;321-326.
4. Fibiger H. C. Cholinergic mechanisms in learning, memory and dementia: A review of recent evidence. Trends Neurosci. 14:1991;220-223.
5. Fischer W., Chen K. S., Gage F. H., Björklund A. Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol. Aging. 13:1991;9-23.
6. Fischer W., Gage F. H., Björklund A. Degenerative changes in forebrain cholinergic nuclei correlate with cognitive impairments in aged rats. Eur. J. Neurosci. 1:1989;34-45.
7. Gibbs R. B. Expression of estrogen receptor-like immunoreactivity by different subgroups of basal forebrain cholinergic neurons in gonadectomized male and female rats. Brain Res. 720:1996;61-68.
8. Gibbs R. B. Fluctuations in Relative Levels of Choline Acetyltransferase mRNA in Different Regions of the Rat Basal Forebrain Across the Estrus Cycle: Effects of Estrogen and Progesterone. J. Neurosci. 16:1996;1049-1055.
9. Gibbs R. B. Effects of estrogen on basal forebrain cholinergic neurons vary as a function of dose and duration of treatment. Brain Res. 757:1997;10-16.
10. Gibbs R. B. Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement. Brain Res. 1998.
11. Gibbs R. B., Hashash A., Johnson D. A. Effects of estrogen on potassium-evoked acetylcholine release in the hippocampus and overlying cortex of adult rats. Brain Res. 749:1997;143-146.
12. NGFR. Exp. Neurol. 116:1992;23-39.
13. NGFR. J. Comp. Neurol. 341:1994;324-339.
14. Gibbs R. B., Wu D.-H., Hersh L., Pfaff D. W. Effects of estrogen replacement on relative levels of ChAT, TrkA and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats. Exp. Neurol. 129:1994;70-80.
15. Hempstead B. L., Martin-Zanca D., Kaplan D. R., Chao M. V. High affinity NGF binding requires co-expression of the trk proto-oncogene and the low affinity NGF receptor. Nature. 350:1991;678-683.
16. Hempstead B. L., Rabin S. J., Kaplan L., Reid S., Parada L. F., Kaplan D. R. Overexpression of the trk tyrosine kinase rapidly accelerates nerve growth factor-induced differentiation. Neuron. 9:1992;883-896.
17. Henderson V. W. The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology. 48:1997;S27-S35.
18. Henderson V. W., Watt L., Buckwalter J. G. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology. 21:1996;421-430.
19. Holtzman D. M., Kilbridge J., Emmett Y. L., Cunningham E. T. J., Lenn N. J., Clary D. O., Reichardt L. F., Mobley W. C. TrkA expression in the CNS: Evidence for the existence of several novel NGF-responsive CNS neurons. J. Neurosci. 15:1995;1567-1576.
20. Honjo H., Tanaka K., Kashiwagi T., Urabe M., Hayashi O. M., Hayashi K. Senile dementia-Alzheimer's type and estrogen. Horm. Metab. Res. 27:1994;204-207.
21. Jones D. N., Barnes J. C., Kirkby D. L., Higgins G. A. Age-associated impairments in a test of attention: evidence for involvement of cholinergic systems. J. Neurosci. 15:1995;7282-7292.
22. Jones D. N., Higgins G. A. Effect of scopolamine on visual attention in rats. Psychopharmacology. 120:1995;142-149.
23. Koh S., Chang P., Collier T. J., Loy R. Loss of NGF receptor immunoreactivity in basal forebrain neurons of aged rats: Correlation with spatial memory impairment. Brain Res. 498:1989;397-404.
24. Koh S., Loy R. Age-related loss of nerve growth factor sensitivity in rat basal forebrain neurons. Brain Res. 440:1988;396-401.
25. Lawrence A. D., Sahakian B. J. Alzheimer disease, attention, and the cholinergic system. Alz. Dis. Assoc. Disor. 9:1995;43-49.
26. LeFevre J., McClintock M. K. Reproductive senescence in female rats: A longitudinal study of individual differences in estrous cycles and behavior. Biol. Reprod. 38:1988;780-789.
27. Luine V. N. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 89:1985;484-490.
28. McEntee W. J., Crook T. H. Cholinergic function in the aged brain: Implications for treatment of memory impairments associated with aging. Behav. Pharmacol. 3:1992;327-336.
29. McMillan P. J., Singer C. A., Dorsa D. M. The effects of ovariectomy and estrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of adult female Sprague-Dawley rat. J. Neurosci. 16:1996;1860-1865.
30. Mufson E. J., Lavine N., Jaffar S., Kordower J. H., Quirion R., Saragovi H. U. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp. Neurol. 146:1997;91-103.
31. Mufson E. J., Li J.-M., Sobreviela T., Kordower J. H. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. NeuroReport. 8:1996;25-29.
32. Muir J. L., Everitt B. J., Robbins T. W. AMPA-induced excitotoxic lesions of the basal forebrain: A significant role for the cortical cholinergic system in attentional function. J. Neurosci. 14:1994;2313-2326.
33. Muir J. L., Everitt B. J., Robbins T. W. Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacol. 118:1995;82-92.
34. Muir J. L., Page K. J., Sirinathsinghji D. J., Robbins T. W., Everitt B. J. Excitotoxic lesions of basal forebrain cholinergic neurons effects on learning, memory and attention. Behav. Brain Res. 57:1993;123-131.
35. O'Malley C. A., Hautamaki R. D., Kelley M., Meyer E. M. Effects of ovariectomy and estradiol benzoate on high affinity choline uptake, ACh synthesis, and release from rat cerebral cortical synaptosomes. Brain Res. 403:1987;389-392.
36. Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., Hagino N. Low-dose estrogen replacement therapy for Alzheimer disease in women. Menopause. 1:1994;125-130.
37. Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., Hagino N. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: Seven case reports. Dementia. 6:1995;99-107.
38. Olton D. S. Dementia: Animal models of the cognitive impairments following damage to the basal forebrain cholinergic system. Brain Res. Bull. 25:1990;499-502.
39. Paganini-Hill A., Henderson V. W. Estrogen replacement therapy and risk of Alzheimer's disease. Arch. Intern. Med. 156:1996;2213-2217.
40. Paxinos G., Watson C. The Rat Brain in Stereotaxic Atlas. 1986;Academic Press, London.
41. Perry E. K., Perry R. H., Blessed G., Tomlinson B. E. Necropsy evidence of cholinergic deficits in senile dementia. Lancet. 1:1977;189.
42. Perry E. K., Tomlinson B. E., Blessed G., Bergmann K., Gibson P. H., Perry R. H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2:1978;1457.
43. Segal R. A., Greenberg M. E. Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19:1996;463-489.
44. Singh M., Meyer E. M., Millard W. J., Simpkins J. W. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 644:1994;305-312.
45. Smith M. L., Booze R. M. Cholinergic and GABAergic neurons in the nucleus basalis region of young and aged rats. Neuroscience. 67:1995;679-688.
46. Sobreviela T., Clary D. O., Reichardt L. F., Brandabur M. M., Kordower J. H., Mufson E. J. TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J. Comp. Neurol. 350:1994;587-611.
47. Tang M.-X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
48. Thoenen H., Bandtlow C., Heumann R. The physiological function of nerve growth factor in the central nervous system: Comparison with the periphery. Rev. Physiol. Biochem. Pharmacol. 109:1987;145-178.
49. Toran-Allerand D., Miranda R. C., Bentham W. D. L., Sohrabji F., Brown T. J., Hochberg R. B., MacLusky N. J. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc. Natl. Acad. Sci. USA. 89:1992;4668-4672.
50. Uhl G. R. In Situ Hybridization in Brain. 1986;Plenum Press, New York.
51. Voytko M. L. Cognitive functions of the basal forebrain cholinergic system in monkeys: Memory or attention. Behav. Brain Res. 75:1996;13-25.
52. Voytko M. L., Olton D. S., Richardson R. T., Gorman L. K., Tobin J. R., Price D. L. Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J. Neurosci. 14:1994;167-186.
53. Voytko M. L., Olton D. S., Richardson R. T., Gorman L. K., Tobin J. R., Price D. L. Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J. Neurosci. 14:1995;167-186.
54. Weinstock M. The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update. Neurodegeneration. 4:1995;349-356.
55. Wenk G. L. The nucleus basalis magnocellularis cholinergic system: One hundred years of progress. Neurobiol. Learning Mem. 67:1997;85-95.
56. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T., DeLong M. R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
57. Woolf N. J. Cholinergic systems in mammalian brain and spinal cord. Prog. Neurobiol. 37:1991;475-524.
58. Zhou J., Valletta J. S., Grimes M. L., Mobley W. C. Multiple levels for regulation of TrkA in PC12 cells by nerve growth factor. J. Neurochem. 65:1995;1146-1156.